Quality assurance in rectal cancer treatment

Digestive Diseases

Volumn 30, Issue SUPPL.2, 2012, Pages 126-131

  Van De Velde, C J H ^a   Van Den Broek, C B M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; Preoperative radiotherapy; Quality assurance; Surgery; Total mesorectal excision

Indexed keywords

BEVACIZUMAB; CETUXIMAB;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONFERENCE PAPER; EUROPE; HEALTH CARE COST; HUMAN; INTERNATIONAL COOPERATION; MEDICAL AUDIT; NATIONAL HEALTH SERVICE; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; QUALITY CONTROL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM SURGERY; RECURRENCE RISK; TOTAL MESORECTAL EXCISION; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

CARCINOMA; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; MEDICAL AUDIT; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 84870770095     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000342041     Document Type: Conference Paper

References (12)

1. McArdle CS, Hole D: Impact of variabilityamong surgeons on postoperative morbidityand mortality and ultimate survival. BMJ1991;302:1501-1505.
2. Bernstein TE, Endreseth BH, Romundstad P,Wibe A: Circumferential resection marginas a prognostic factor in rectal cancer. Br JSurg 2009;96:1348-1357.
3. Wibe A, Rendedal PR, Svensson E, NorsteinJ, Eide TJ, Myrvold HE, et al: Prognostic significanceof the circumferential resectionmargin following total mesorectal excisionfor rectal cancer. Br J Surg 2002;89:327-334.
4. Marijnen CA, Nagtegaal ID, Kapiteijn E,Kranenbarg EK, Noordijk EM, van KriekenJH, et al: Radiotherapy does not compensatefor positive resection margins in rectal cancerpatients: report of a multicenter randomizedtrial. Int J Radiat Oncol Biol Phys2003;55:1311-1320.
5. Quirke P, Steele R, Monson J, Grieve R,Khanna S, Couture J, et al: Effect of the planeof surgery achieved on local recurrence inpatients with operable rectal cancer: a prospectivestudy using data from the MRCCR07 and NCIC-CTG CO16 randomisedclinical trial. Lancet 2009;373:821-828.
6. van Gijn W, Marijnen CA, Nagtegaal ID,Kranenbarg EM, Putter H, Wiggers T, et al:Preoperative radiotherapy combined withtotal mesorectal excision for resectable rectalcancer: 12-year follow-up of the multicentre,randomised controlled TME trial. LancetOncol 2011;12:575-582.
7. Marr R, Birbeck K, Garvican J, Macklin CP,Tiffin NJ, Parsons WJ, et al: The modern abdominoperinealexcision: the next challengeafter total mesorectal excision. Ann Surg2005;242:74-82.
8. Wibe A, Moller B, Norstein J, Carlsen E, WiigJN, Heald RJ, et al: A national strategic changein treatment policy for rectal cancer-implementationof total mesorectal excision asroutine treatment in Norway. A national audit.Dis Colon Rectum 2002;45:857-866.
9. Pahlman L, Bohe M, Cedermark B, DahlbergM, Lindmark G, Sjodahl R, et al: The Swedishrectal cancer registry. Br J Surg 2007;94:1285-1292.
10. Sant M, Gatta G: The EUROCARE database.IARC Sci Publ 1995;15-31.
11. Birkmeyer JD, Siewers AE, Finlayson EV,Stukel TA, Lucas FL, Batista I, et al: Hospitalvolume and surgical mortality in the UnitedStates. N Engl J Med 2002;346:1128-1137.
12. Frykholm GJ, Glimelius B, Pahlman L: Preoperativeor postoperative irradiation in adenocarcinomaof the rectum: final treatmentresults of a randomized trial and an evaluationof late secondary effects. Dis Colon Rectum1993;36:564-572.